Enhanced lipid peroxidation in patients positive for antiphospholipid antibodies

Blood

Volumn 90, Issue 10, 1997, Pages 3931-3935

  Luliano, Luigi ^b   Praticò, Domenico ^b   Ferro, Domenico ^b   Pittoni, Valerio ^b   Valesini, Guido ^b   Lawson, John ^b   FitzGerald, Garret A ^b   Violi, Francesco ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLIPIN; PHOSPHOLIPID ANTIBODY;

ADOLESCENT; ADULT; ANTICOAGULATION; ARACHIDONIC ACID METABOLISM; ARTICLE; CATALYSIS; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; FEMALE; HUMAN; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; SYSTEMIC LUPUS ERYTHEMATOSUS; URINARY EXCRETION; VEIN THROMBOSIS;

EID: 0030733228     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v90.10.3931     Document Type: Article

References (30)

1. Harris EN, Gharavi AE, Boey ML, Patel BM, Mackworth-Young CG, Loizou S, Hughes GRV: Anticardiolipin antibodies: Detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 2:1211, 1983
2. Hughes GRV: The antiphospholipid syndrome: Ten years on. Lancet ii:341, 1993
3. Ferro D, Saliola M, Quintarelli C, Valesini G, Basili S, Grandilli MA, Bonavita MS, Violi F: Methods for detecting lupus anticoagulant and their relation to thrombosis and miscarriage in patients with systemic lupus erythematosus. J Clin Pathol 45:332, 1992
4. Vaarala O, Palosuo T, Kleemola M, Aho K: Anticardiolipin response in acute infections. Clin Immunol Immunopathol 41:8, 1986
5. Violi F, Ferro D, Quintarelli C, Alessandri C, Saliola M, Valesini G, Balsano F: Dilute aPTT prolongation by antiphospholipid antibodies in patients with liver cirrhosis. Thromb Haemostas 63:183, 1990
6. Vaarala O, Mänttäri M, Manninen U, Tenkanen L, Puurunen M, Aho K, Palosuo T: Anticardiolipin antibodies and risk of miocardial infarction in prospective cohort of middle aged men. Circulation 91:23, 1995
7. Hörkko S, Miller E, Dudl E, Reaven P, Curtiss LK, Zvaifler NJ, Terkeltaub R, Pierangeli SS, Branch DW, Palinski W, Witztum JL: Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein. J Clin Invest 98:815, 1996
8. 2-like compounds are produced in vivo in humans by a non-cyclooxygenase, free radical-catalyzed mechanism. Proc Natl Acad Sci USA 87:9383, 1990
9. 2 isoprostane) are formed in situ on phospholipids. Proc Natl Acad Sci USA 89:10721, 1992
10. 2 isoprostane) metabolites in human urine and plasma. J Biol Chem 268:4161, 1993
11. 2α specific analysis of an isoeicosanoid as an index of oxidant stress in vivo. Br J Clin Pharmacol 42:15, 1996
12. Reilly M, Delanty N, Lawson JA, FitzGerald GA: Modulation of oxidant stress in vivo in chronic cigarette smokers. Circulation 94:19, 1996
13. 2α generation during coronary reperfusion: A potential quantitative marker of oxidative stress in vivo. Circulation 95:2492, 1997
14. Loft S, Astrup A, Buemann B, Poulsen HE: Oxidative DNA damage correlates with oxygen consumption in humans. FASEB J 8:534, 1994
15. Bolli R, Zughaib M, Li XY, Sun JS, Triana JF, McCay PB: Recurrent ischemia in the canine earth causes recurrent bursts of free radical production that have a cumulative effect on contractile function. J Clin Invest 96:1066, 1995
16. 2α-I and its identification in biological fluids. Tetrahedron Letters 37:4849, 1996
17. 2α. J Biol Chem 270:9800, 1995
18. 2α by human monocytes. Discriminate production by reactive oxygen species and prostaglandin endoperoxide synthase-2. J Biol Chem 271:8919, 1996
19. Tan EM, Cohen AS, Fries JF, Massie AT, McShane DJ, Rothfield NF, Green Schaller J, Talal N, Winchester RJ: The 1982 revised criteria for classification of systemic lupus erythematosus. Arthritis Rheum 25:1271, 1982
20. Ferro D, Pittoni V, Quintarelli C, Basili S, Saliola M, Caroselli C, Valesini G, Violi F: Coexistence of antiphospholipid antibodies and endothelial perturbation in systhemic lupus erythematosus patients with ongoing prothrombotic state. Circulation 95:1425, 1997
21. Harris EN, Gharavi AE, Patel SP, Hughes GRV: Evaluation of the anticardiolipin antibody test: Report of an international workshop held 4 April 1986. Clin Exp Immunol 68:214, 1987
22. Armitage P, Berry G: Statistical methods in medical research. Oxford, UK, Blackwell Scientific Publication, 1990
23. Mohan C, Datta SK: Lupus: Key pathogenic mechanisms and contributing factors. Clin Immunol Immunopathol 77:209, 1995
24. Lynch SM, Morrow JD, Roberts II JL, Frei B: Formation of non-cyclooxygenase-derived prostanoids (F2-isoprostanes) in plasma and low density lipoprotein exposed to oxidative stress in vitro. J Clin Invest 93:998, 1994
25. O'Connor DE, Mihelich ED, Coleman MC: Stereochemical course of the autoxidative cyclization of lipid hydroperoxides to prostaglandin-like bicyclo endoperoxides. J Am Chem Soc 106:3577, 1984
26. Halliwell B, Gutteridge GMC: Free radicals, ageing, and disease, in Halliwell B, Gutteridge GMC (eds): Free Radicals in Biology and Medicine. New York, NY, Oxford University Press, 1989, p 416
27. 2α: an index of oxidative stress. Circulation 94:1611a, 1996 (abstr)
28. Beutler B, Cerami A: The biology of cachectin/TNF. A primary mediator of the host response. Ann Rev Immunol 7:625, 1989
29. Al-Janadi M, Al-Balla S, Al-Dalaan A, Raziuddin S: Cytokine profile in systemic lupus erythematosus, rheumatoid arthritis and other rheumatic diseases. J Clin Immunol 13:58, 1993
30. Stein CM, Longmire AW, Minton T, Roberts LJ, Pincus T, Morrow JD: Cyclosporine-induced alterations in renal function are not associated with lipid peroxidation. Transplantation 58:386, 1994